Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Marginal significance was found according to sex (p = 0.059) and hypertension (p = 0.060).Patient characteristics according to the response at 6 months treatment of TNF inhibitors.Characteristics, n (%)Remission (n = 29)No remission (n = 69)p-valueSex0.059Male9 (31.0)10 (14.5)Female20 (69.0)59 (85.5)Age51.4 ± 13.453.6 ± 13.90.399 < 6526 (89.7)53 (76.8)0.142 ≥ 653 (10.3)16 (23.2)BMI, kg/m223.4 ± 3.022.3 ± 3.80.220 < 2313 (44.8)42 (60.9)0.144 ≥ 2316 (55.2)27 (39.1)Duration of rheumatoid arthritis, months103.9 ± 87.8111.0 ± 69.20.666Rheumatoid factor0.329Positive20 (69.0)54 (78.3)Negative9 (31.0)15 (21.7)ACPA0.177Positive17 (34.6)49 (79.0)Negative9 (65.4)13 (21.0)Concomitant drugHydroxychloroquine0.902 Yes16 (55.2)39 (56.5) No13 (44.8)30 (43.5)Leflunomide0.665 Yes10 (34.5)27 (39.1) No19 (65.5)42 (60.9)Methotrexate0.319 Yes19 (65.5)52 (75.4) No10 (34.5)17 (24.6)Sulfasalazine0.111 Yes7 (24.1)7 (10.1) No22 (75.9)62 (89.9)Tacrolimus0.986 Yes5 (17.2)12 (17.4) No24 (82.8)57 (82.6)ComorbidityDiabetes0.669 Yes1 (3.6)5 (7.2) No27 (96.4)64 (92.8)Dyslipidemia1.000 Yes3 (10.7)9 (13.0) No25 (89.3)60 (87.0)Hypertension0.060 Yes1 (3.6)14 (20.3) No27 (96.4)55 (79.7)Osteoporosis0.725 Yes4 (14.3)7 (10.1) No24 (85.7)62 (89.9)Vitamin D deficiency0.272 Yes1 (3.6)9 (13.0) No27 (96.4)60 (87.0)Baseline DAS28 with its subcomponentsDAS285.8 ± 1.25.8 ± 1.10.696Tender joint count 289.6 ± 8.310.7 ± 74.30.782Swollen joint count 286.6 ± 7.17.5 ± 5.70.872Global health55.3 ± 18.562.4 ± 20.20.167ESR54.7 ± 29.549.5 ± 27.30.379CRP3.0 ± 4.42.1 ± 2.50.113BMI: body mass index; ACPA: anticyclic citrullinated peptide antibody; DAS28: disease activity score 28 joints; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Genomic DNA of the patients was isolated from ethylenediaminetetraacetic acid (EDTA): blood samples using the QIAamp DNA Blood Mini Kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer’s protocol.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-α inhibitors and development of machine learning models
Study design awaiting verification · Scientific Reports · 2021
Original publication title
Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-α inhibitors and development of machine learning models
© The Author(s) 2021
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Toll-like receptor (TLR)-4 and TLR9 are known to play important roles in the immune system, and several studies have shown their association with the development of rheumatoid arthritis (RA) and regulation of tumor necrosis factor alpha (TNF-α). However, studies that investigate the association between TLR4 or TLR9 gene polymorphisms and remission of the disease in RA patients taking TNF-α inhibitors have yet to be conducted. In this context, this study was designed to investigate the effects of polymorphisms in TLR4 and TLR9 on response to TNF-α inhibitors and to train various models using machine learning approaches to predict remission.
A total of six single nucleotide polymorphisms (SNPs) were investigated. Logistic regression analysis was used to investigate the association between genetic polymorphisms and response to treatment. Various machine learning methods were utilized for prediction of remission. After adjusting for covariates, the rate of remission of T-allele carriers of TLR9 rs352139 was about 5 times that of the CC-genotype carriers (95% confidence interval (CI) 1.325 to 19.231, p = 0.018). Among machine learning algorithms, multivariate logistic regression and elastic net showed the best prediction with the area under the receiver-operating curve (AUROC) value of 0.71 (95% CI 0.597 to 0.823 for both models).
This study showed an association between a TLR9 polymorphism (rs352139) and treatment response in RA patients receiving TNF-α inhibitors. Moreover, this study utilized various machine learning methods for prediction, among which the elastic net provided the best model for remission prediction.
Authors’ abstract
Toll-like receptor (TLR)-4 and TLR9 are known to play important roles in the immune system, and several studies have shown their association with the development of rheumatoid arthritis (RA) and regulation of tumor necrosis factor alpha (TNF-α). However, studies that investigate the association between TLR4 or TLR9 gene polymorphisms and remission of the disease in RA patients taking TNF-α inhibitors have yet to be conducted. In this context, this study was designed to investigate the effects of polymorphisms in TLR4 and TLR9 on response to TNF-α inhibitors and to train various models using machine learning approaches to predict remission.
A total of six single nucleotide polymorphisms (SNPs) were investigated. Logistic regression analysis was used to investigate the association between genetic polymorphisms and response to treatment. Various machine learning methods were utilized for prediction of remission. After adjusting for covariates, the rate of remission of T-allele carriers of TLR9 rs352139 was about 5 times that of the CC-genotype carriers (95% confidence interval (CI) 1.325 to 19.231, p = 0.018). Among machine learning algorithms, multivariate logistic regression and elastic net showed the best prediction with the area under the receiver-operating curve (AUROC) value of 0.71 (95% CI 0.597 to 0.823 for both models).
This study showed an association between a TLR9 polymorphism (rs352139) and treatment response in RA patients receiving TNF-α inhibitors. Moreover, this study utilized various machine learning methods for prediction, among which the elastic net provided the best model for remission prediction.
Publication and source details
Original title: Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-α inhibitors and development of machine learning models
Woorim Kim; Tae Hyeok Kim; Soo Jin Oh; Hyun Jeong Kim; Joo Hee Kim; Hyoun-Ah Kim; Ju-Yang Jung; In Ah Choi; Kyung Eun Lee
Scientific Reports · 2021
© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.http://dx.doi.org/10.13039/501100003725National Research Foundation of KoreaNRF-2020R1F1A1069718Lee Kyung EunRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T11:32:27.333096+00:00
DOI: 10.1038/s41598-021-99625-x · PMC8505487